NeuroPace Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	18.18	6.73	19.31	26.76	4.12
Short-Term Investments	48.4	70.8	96.4	11.69	0.97
Cash & Cash Equivalents	66.58	77.53	115.71	38.45	5.09
Cash Growth	-14.13%	-32.99%	200.97%	655.01%	-
Receivables	12.31	7.48	7.09	8.4	6.02
Inventory	11.21	9.71	7.82	6.91	7.9
Other Current Assets	2.62	2.99	2.2	0.81	1.25
Total Current Assets	92.72	97.71	132.82	54.56	20.26
Property, Plant & Equipment	14.41	15.9	0.6	0.52	0.81
Other Long-Term Assets	0.52	0.49	0.14	0.87	0.03
Total Long-Term Assets	14.93	16.39	0.75	1.39	0.84
Total Assets	107.65	114.11	133.56	55.95	21.1
Accounts Payable	2.33	2.15	1.38	0.95	0.9
Deferred Revenue	1.09	0	0	0	0
Current Debt	1.63	1.42	0	2.04	62.8
Other Current Liabilities	11.18	7.41	7.92	6.6	11.45
Total Current Liabilities	16.23	10.98	9.3	9.6	75.15
Long-Term Debt	70.77	68.35	49.85	50.82	0
Other Long-Term Liabilities	0	0	0.91	1.94	1.73
Total Long-Term Liabilities	70.77	68.35	50.76	52.77	1.73
Total Liabilities	87	79.33	60.06	62.36	76.88
Total Debt	72.4	69.77	49.85	52.86	62.8
Debt Growth	3.77%	39.96%	-5.71%	-15.82%	-
Retained Earnings	-503.81	-470.85	-423.77	-387.69	-363.64
Comprehensive Income	0	-1.11	-0.27	0.03	0
Shareholders' Equity	20.65	34.78	73.5	-147.83	-129.35
Net Cash / Debt	-5.82	7.76	65.86	-14.42	-57.71
Net Cash / Debt Growth	-	-88.21%	-	-	-
Net Cash Per Share	-0.23	0.32	3.97	-70.66	-285.78
Working Capital	76.49	86.74	123.52	44.97	-54.89
Book Value Per Share	0.80	1.41	4.43	-724.42	-640.58

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).